Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Epigenetics in Drug Discovery

Craig Malcolm's Biography



Craig Malcolm, Strategic Collaborations Manager, Promega UK Ltd

After receiving his PhD in Neurochemistry from St Andrews University, Dr Malcolm spent seven years in the pharmaceutical industry as a Team Leader in Molecular Pharmacology (Vernalis), developing cell-based assays and supporting drug discovery screening projects. After several more years in product development at PerkinElmer, and various other commercially-focussed roles in several other UK-based Life Science companies (Scientifica, Roche Applied Science), he joined Promega UK and is currently Strategic Collaborations Manager with a focus on new and emerging technology platforms for drug discovery and biologics.

Craig Malcolm Image

Tools for Epigenetic Target Based Drug Discovery – Assays for Methyltranferase/Demethylase Activity and Histone Binding by NanoBRET Technology

Tuesday, 26 January 2016 at 14:15

Add to Calendar ▼2016-01-26 14:15:002016-01-26 15:15:00Europe/LondonTools for Epigenetic Target Based Drug Discovery – Assays for Methyltranferase/Demethylase Activity and Histone Binding by NanoBRET TechnologyEpigenetics in Drug Discovery in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com

This technology snapshot presentation will introduce a range of novel technologies from Promega applicable drug discovery programmes for epigenetic targets.


Add to Calendar ▼2016-01-26 00:00:002016-01-27 00:00:00Europe/LondonEpigenetics in Drug DiscoveryEpigenetics in Drug Discovery in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com